Gene: SPRYD4
Official Full Name: SPRY domain containing 4provided by HGNC
Gene Summary: Located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13763 | SPRYD4 Knockout cell line (HeLa) | Human | SPRYD4 | 1:3~1:6 | Negative | Online Inquiry |
KO13764 | SPRYD4 Knockout cell line (HCT 116) | Human | SPRYD4 | 1:2~1:4 | Negative | Online Inquiry |
KO13765 | SPRYD4 Knockout cell line (HEK293) | Human | SPRYD4 | 1:3~1:6 | Negative | Online Inquiry |
KO13766 | SPRYD4 Knockout cell line (A549) | Human | SPRYD4 | 1:3~1:4 | Negative | Online Inquiry |
SPRYD4 Gene Knockout Cell Lines are engineered cellular models specifically designed to facilitate the study of the SPRYD4 gene's role in various biological processes. Knockout cell lines are characterized by the targeted inactivation of a gene of interest, providing researchers with a powerful tool to investigate the functional consequences of gene loss. In the case of SPRYD4, these knockout models allow for the exploration of the gene’s involvement in cellular signaling pathways, stress responses, and potential implications in disease states.
The primary mechanism by which these cell lines operate is through the disruption of the SPRYD4 gene, achieved via techniques such as CRISPR/Cas9 or RNA interference. This results in the absence or significant reduction of SPRYD4 protein expression, allowing scientists to assess phenotypic changes in cellular behavior, gene expression, and metabolic processes under controlled experimental conditions. The ability to study the SPRYD4 gene's loss-of-function effects enriches our understanding of its biological significance and potential therapeutic avenues.
The scientific importance of SPRYD4 Gene Knockout Cell Lines spans research areas including cancer biology, immunology, and neurobiology. These models are invaluable in deciphering the molecular mechanisms underlying diseases where SPRYD4 may play a pivotal role, thus providing insights that could lead to novel therapeutic strategies and biomarker development.
Compared to alternative models, such as wild-type cells or transient transfection systems, the SPRYD4 Gene Knockout Cell Lines offer several advantages. They provide stable, reproducible results over extended study periods and allow for assessments of gene function in a more physiologically relevant context. Additionally, as these knockout lines can be generated from various cell types, including patient-derived cells, they can be tailored to specific research objectives, enhancing their versatility and relevance.
For researchers and clinicians alike, SPRYD4 Gene Knockout Cell Lines represent a significant advancement in the toolkit for molecular biology. Their ability to deliver precise insights into gene functionality directly supports the development of targeted therapies and personalized medicine approaches. By choosing these knockout cell lines, users leverage a product rooted in cutting-edge genetic engineering, backed by a commitment to quality and innovation.
Our company specializes in creating high-quality biological products designed to empower scientific discovery. With an expert team dedicated to advancing research technologies, we are committed to providing researchers with the tools they need to unlock new scientific possibilities.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.